Journals / Eurasian Journal of Medicine / 2011 / Cilt: 43 - Sayı: 1

Kronik hastalık anemisi ve demir eksikliği anemisi birlikteliğinin tanısında serum transferrin reseptör düzeyinin önemi

The significance of serum transferrin receptor levels in the diagnosis of the coexistence of anemia of chronic disease and iron deficiency anemia

Pages
9–12
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Comparing groups with each other revealed significant differences (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Iron deficiency anemia is the most common cause of microcytic anemia throughout the world.
📊
Key Findings & Data:Ferritin levels are good indicators of iron stores; however, levels may increase irrespective of iron stores in cases of chronic disease.
💡
Conclusion & Impact:Comparing groups with each other revealed significant differences (p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: Iron deficiency anemia is the most common cause of microcytic anemia throughout the world. Ferritin levels are good indicators of iron stores; however, levels may increase irrespective of iron stores in cases of chronic disease. Therefore, it is difficult to diagnose iron deficiency anemia coexisting with anemia of chronic disease. Materials and Methods: To determine the level of transferrin receptor in subjects, 30 patients with iron deficiency anemia, 30 patients with anemia of chronic disease and 30 patients with both diseases were included in the study.Results: Mean serum transferrin receptor levels were 5.99±2.98 mg/L in the iron deficiency anemia group, 1.90±1.15 mg/L in the anemia of chronic disease group and 3.07±0.90 mg/L in the combination group. Comparing groups with each other revealed significant differences (p

Özet

Amaç: Demir eksikliği anemisi tüm dünyada en sık görülen mikrositer anemi sebebidir. Ferritin düzeyi demir depolarının iyi bir göstergesi olmasına rağmen kronik hastalık durumlarında demir depolarından bağımsız olarak yükselebilmektedir. Bu yüzden kronik hastalık anemisiyle birlikte olan demir eksikliği anemisinin tanısını koymak zordur. Gereç ve Yöntem: Transferrin reseptör düzeyinin yararını değerlendirmek amacıyla demir eksikliği anemisi, kronik hastalık anemisi ve kombine olmak üzere her gruptan 30'ar hasta çalışmaya alındı.Bulgular: Ortalama serum transferrin reseptör düzeyleri demir eksikliği anemisinde 5.99±2.98 mg/L, kronik hastalık anemisinde 1.90±1.15 mg/L ve kombine olan grupta ise 3.07±0.90 mg/L olarak bulundu. Gruplar birbirleri ile karşılaştırıldığında aralarında anlamlı farklılık saptandı (p

🔖

Cite This Article

SENNAROĞLU, E., YOKUŞ, O., BALÇIK, Ş. Ö., HELVACI, M. R., ALBAYRAK, M., YILMAZ, B. (2022). Kronik hastalık anemisi ve demir eksikliği anemisi birlikteliğinin tanısında serum transferrin reseptör düzeyinin önemi. Eurasian Journal of Medicine, Cilt: 43 - Sayı: 1, 9–12. https://ajindex.com/articles/509258

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (8)

  1. Kern WF. PDQ Hematology. BC Decker, Hamilton, 2002, pp. 30- 33, 49-65
  2. Fitzsimons EJ, Brock JH. The anaemia of chronic disease. BMJ. 2001; 7: 811-2
  3. Bunn HF. Anaemia associated with chronic disorders. Harrisons Principles Of Internal Medicine: Wilson JD. Brounwald E, Isselbacker KJ, Petersdorf RG, Martin JB, Fauci AS, Root RK. 13th Ed. Interamericana de Espana. Mc Graw-Hill 1994; 1732-4
  4. Teehan GS, Bahdouch D, Ruthazer R, Balakrishnan VS, Snydman DR, Jaber BL. Iron storage indices: Novel predictors of bacteremia in hemodialysis patients initiating intravenous iron therapy. Clin Infect Dis 2004; 38: 1090-4. [CrossRef] 5) Vreugdenhil G, Manger B, Nieuwenhuizen C, Feelders RA, van Eijk HG, Swaak AJ. Iron stores and serum transferrin receptor levels during recombinant human erythropoietin treatment of anemia in rheumatoid arthritis. Ann Hematol. 1992; 65: 265-8. [CrossRef] 6) Shih YJ, Baynes RD, Hudson BG, Cook JD. Characterization and quantitation of the circulating forms of serum transferrin receptor using domain-specific antibodies. Blood. 1993; 81: 234-8
  5. Phiri KS, Calis JC, Kachala D, Borgstein E, Waluza J, Bates I et al. Improved method for assessing iron stores in the bone marrow. J Clin Pathol. 2009; 62: 685-9. [CrossRef] 8) Koulaouzidis A, Said E, Cottier R, Saeed AA. Soluble transferrin receptors and iron deficiency, a step beyond ferritin. A systematic review. J Gastrointestin Liver Dis. 2009; 18: 345-52
  6. Agarwal N, Prchal JT. Anemia of chronic disease (anemia of inflammation). Acta Haematol. 2009; 122: 103-8. [CrossRef] 10) Punnonen K, Irjala K, Rajamäki A. Iron-Deficiency Anemia Is Associated with High Concentrations of Transferrin Receptor in Serum. Clin Chem. 1994; 40: 774-6
  7. Weiss G. Iron metabolism in the anemia of chronic disease. Biochim Biophys Acta. 2009; 1790: 682-93
  8. Chijiwa T, Nishiya K, Hashimoto K. Serum transferrin receptor levels in patients with rheumatoid arthritis are correlated with indicators of anaemia. Clin Rheumatol 2001; 20: 307-13. [CrossRef] 13) Chouliaras GL, Premetis E, Tsiftis G, Drosatou P, Papassotiriou I, Stamoulakatou A et al. Serum transferrin receptors: Distribution and diagnostic performance in pre-school children. Blood Cells Mol Dis. 2009; 43: 163-8. [CrossRef] 14) Lin XM, Zhang J, Zou ZY, Long Z, Tian W. Evaluation of serum transferrin receptor for iron deficiency in women of childbearing age. Br J Nutr. 2008; 100: 1104-8. [CrossRef] 15) Skikne BS. Serum transferrin receptor. Am J He